Like I said its rolling up into earnings on 11/15 and we know they are gonna be stellar.Insiders were granted options @ .27 many months ago and held even though we ran to $1.26 with back logged sales due to the virus.There are no backlogs now and we just did a deal with Codx for a new testing model.The company would like to get back on Naz and with this SS no dilution and the need for testing rising fast and we have one of the best covid tests on the market we're gonna be good to go